Kan Li
Impact in
- Obstetrics and Gynecology top 1%
- Endometrial and Cervical Cancer Treatments
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 16
- Cancer Immunotherapy and Biomarkers 10
-
- Endometrial and Cervical Cancer Treatments 13
- Co-authors
- Sheng Luo (23 shared papers)Mahmut Gümüş (10 shared papers)Bradley J. Monk (11 shared papers)Pamela Salman (11 shared papers)Vanessa Samouëlian (11 shared papers)Coraline Dubot (10 shared papers)Ronnie Shapira‐Frommer (10 shared papers)Domenica Lorusso (14 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)International Journal of Gynecological Cancer (4 papers)Statistics in Medicine (4 papers)HPB (3 papers)Gynecologic Oncology (2 papers)
- Partner nations
- United StatesChinaItaly
In The Last Decade
Kan Li
56 papers receiving 1.9k citations
Kan Li's Hit Papers
Peers
Comparison fields: 5 of 113
- Obstetrics and Gynecology 352
- Oncology 538
- Hepatology 108
- Statistics and Probability 111
- Reproductive Medicine 105
Countries citing papers authored by Kan Li
This map shows the geographic impact of Kan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kan Li more than expected).
Fields of papers citing papers by Kan Li
This network shows the impact of papers produced by Kan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kan Li. The network helps show where Kan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Kan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer Hit paper breakdown → | 2021 | 619 |
| 2 | Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial Hit paper breakdown → | 2023 | 246 |
| 3 | 2015 | 126 | |
| 4 | 2016 | 114 | |
| 5 | First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826 Hit paper breakdown → | 2023 | 114 |
| 6 | 2017 | 88 | |
| 7 | 2019 | 62 | |
| 8 | 2017 | 60 | |
| 9 | 2021 | 47 | |
| 10 | 2023 | 38 | |
| 11 | 2018 | 35 | |
| 12 | 2017 | 32 | |
| 13 | 2003 | 30 | |
| 14 | 2008 | 27 | |
| 15 | 2017 | 27 | |
| 16 | 2019 | 24 | |
| 17 | 2023 | 24 | |
| 18 | 2016 | 23 | |
| 19 | 2020 | 22 | |
| 20 | 2019 | 21 |
About Kan Li
Kan Li is a scholar working on Oncology, Obstetrics and Gynecology, Epidemiology, Economics and Econometrics and Artificial Intelligence, having authored 59 papers that have together received 2.0k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (13 papers), Cancer Immunotherapy and Biomarkers (10 papers), Statistical Methods and Bayesian Inference (5 papers), Statistical Methods and Inference (5 papers), Neuroendocrine Tumor Research Advances (5 papers), Geochemistry and Geochronology of Asian Mineral Deposits (5 papers), Dementia and Cognitive Impairment Research (4 papers) and Bayesian Methods and Mixture Models (4 papers). The work is most often cited by research in Obstetrics and Gynecology (352 citations), Oncology (538 citations), Hepatology (108 citations), Statistics and Probability (111 citations) and Reproductive Medicine (105 citations). Kan Li has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Sheng Luo, Mahmut Gümüş, Bradley J. Monk, Pamela Salman, Vanessa Samouëlian, Coraline Dubot, Ronnie Shapira‐Frommer, Domenica Lorusso, Krishnansu S. Tewari and Kosei Hasegawa. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Gynecological Cancer, Statistics in Medicine, HPB and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.